Efficacy Of Subsequent Chemotherapy For Patients With Brca1/2 Mutated Platinum-Sensitive Recurrent Epithelial Ovarian Cancer (Eoc) Progressing On Olaparib Vs Placebo: The Solo 2/Engot Ov-21 Trial
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络